Manulife (Manufacturers Life Insurance)’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$299K Buy
36,776
+6,464
+21% +$52.6K ﹤0.01% 2391
2025
Q1
$238K Buy
30,312
+747
+3% +$5.86K ﹤0.01% 2422
2024
Q4
$440K Sell
29,565
-763
-3% -$11.4K ﹤0.01% 2300
2024
Q3
$464K Buy
30,328
+470
+2% +$7.19K ﹤0.01% 2322
2024
Q2
$455K Buy
29,858
+2,123
+8% +$32.3K ﹤0.01% 2258
2024
Q1
$524K Buy
27,735
+1,004
+4% +$19K ﹤0.01% 2194
2023
Q4
$511K Sell
26,731
-75
-0.3% -$1.43K ﹤0.01% 2160
2023
Q3
$481K Sell
26,806
-24,376
-48% -$438K ﹤0.01% 2159
2023
Q2
$1.04M Buy
51,182
+822
+2% +$16.7K ﹤0.01% 1636
2023
Q1
$919K Buy
50,360
+79
+0.2% +$1.44K ﹤0.01% 1682
2022
Q4
$1.03M Buy
50,281
+29,533
+142% +$603K ﹤0.01% 1597
2022
Q3
$543K Sell
20,748
-451
-2% -$11.8K ﹤0.01% 1926
2022
Q2
$537K Buy
21,199
+2,236
+12% +$56.7K ﹤0.01% 2006
2022
Q1
$598K Sell
18,963
-4,148
-18% -$131K ﹤0.01% 2080
2021
Q4
$935 Sell
23,111
-243
-1% -$10 ﹤0.01% 1876
2021
Q3
$814K Sell
23,354
-2,551
-10% -$88.9K ﹤0.01% 1971
2021
Q2
$711K Buy
25,905
+1,966
+8% +$54K ﹤0.01% 2190
2021
Q1
$672K Sell
23,939
-1,430
-6% -$40.1K ﹤0.01% 2113
2020
Q4
$659K Buy
25,369
+1,517
+6% +$39.4K ﹤0.01% 2048
2020
Q3
$409K Buy
23,852
+4,040
+20% +$69.3K ﹤0.01% 2100
2020
Q2
$468K Sell
19,812
-1,755
-8% -$41.5K ﹤0.01% 2002
2020
Q1
$299K Buy
21,567
+732
+4% +$10.1K ﹤0.01% 2093
2019
Q4
$210K Sell
20,835
-1,322
-6% -$13.3K ﹤0.01% 2566
2019
Q3
$226K Buy
22,157
+130
+0.6% +$1.33K ﹤0.01% 2506
2019
Q2
$175K Buy
22,027
+10,084
+84% +$80.1K ﹤0.01% 2711
2019
Q1
$149K Buy
+11,943
New +$149K ﹤0.01% 2510